T1	HMM 125 144	safety and efficacy
T2	HMM 753 784	Rates of serious adverse events
T3	HMM 829 847	serious infections
T4	HMM 891 897	cancer
T5	HMM 941 951	and deaths
T6	HMM 1121 1135	response rates
T7	HMM 1309 1314	Doses
T8	HMM 1442 1456	safety profile
T9	HMM 1502 1525	rates of adverse events
